Lung Cancer

Heather Wakelee MD and David Gandara MD review data from key lung cancer presentations at the 2016 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • Lung Cancer ASCO 2016
    Lung Cancer: Looking Ahead to the 2016 Clinical Oncology Meeting
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2016

    Expires: May 30, 2017

  • LURET: Phase II Study of Vandetanib
    Phase II LURET Study: Vandetanib Monotherapy Active in RET-Rearranged Advanced NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2016

    Expires: June 05, 2017

  • NSCLC Anti–PD-1 Past Progression
    FDA Analysis: Metastatic NSCLC Treated With Anti–PD-1 Therapy Past RECIST Progression
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 06, 2016

    Expires: June 05, 2017

  • Rovalpituzumab Tesirine in SCLC
    Rovalpituzumab Tesirine Safe, Active in Previously Treated SCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2016

    Expires: June 06, 2017

  • BID vs QD CRT in SCLC
    Phase III CONVERT: Twice-Daily vs Once-Daily Concurrent CRT in Limited-Stage SCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2016

    Expires: June 06, 2017

  • CRZ in <i>MET</i>-Rearranged NSCLC
    PROFILE 1001: Crizotinib in Advanced Non-Small-Cell Lung Cancer With MET Exon 14 Alterations
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2016

    Expires: June 06, 2017

  • Lorlatinib in ALK/ROS1+ NSCLC
    Phase I/II Study of Lorlatinib in Advanced ALK+ or ROS1+ NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2016

    Expires: June 06, 2017

  • Chemotherapy in Early-Stage NSCLC
    E1505: Similar Survival Across 4 Different Chemotherapy Regimens in Early-Stage, Resected NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2016

    Expires: June 07, 2017

  • LCT in Oligometastatic NSCLC
    Local Consolidative Therapy in Oligometastatic NSCLC With No Progression on First-line Systemic Treatment
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2016

    Expires: June 08, 2017

  • Alectinib in ALK+ NSCLC
    Phase III J-ALEX: Alectinib vs Crizotinib in ALK Inhibitor–Naïve, ALK-Positive NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 10, 2016

    Expires: June 09, 2017

  • Osimertinib in NSCLC With LM
    BLOOM: Osimertinib Shows Promising Activity in Patients With EGFRm+ Advanced NSCLC and Leptomeningeal Metastases
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 10, 2016

    Expires: June 09, 2017

  • Brigatinib in ALK+ NSCLC
    Phase II ALTA: Brigatinib Has Promising Activity in Crizotinib-Refractory ALK+ NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 13, 2016

    Expires: June 12, 2017

  • Downloadable Slideset
    Lung Cancer: A Review of Key Clinical Studies
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2016

    Expires: August 16, 2017

Faculty

cover img faculity

Heather Wakelee, MD

Associate Professor of Medicine, Oncology
Department of Medicine/Oncology
Stanford University/Stanford Cancer Institute
Stanford, California

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals